scholarly journals Long-Term Efficacy and Safety of Linagliptin in a Japanese Population with Type 2 Diabetes Aged ≥ 60 Years Treated with Basal Insulin: A Randomised Trial

2019 ◽  
Vol 36 (10) ◽  
pp. 2697-2711 ◽  
Author(s):  
Eiichi Araki ◽  
Yuriko Unno ◽  
Yuko Tanaka ◽  
Wataru Sakamoto ◽  
Yuki Miyamoto
Keyword(s):  
Type 2 Diabetes ◽  
Basal Insulin ◽  
Japanese Population ◽  
Randomised Trial ◽  
Efficacy And Safety ◽  
Term Efficacy

Long-Term Efficacy and Safety of Ertugliflozin in Patients (Pts) with Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled with Metformin (MET) Monotherapy—104-Week VERTIS MET Trial

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 1129-P
Author(s):  
SILVINA GALLO ◽  
BERNARD CHARBONNEL ◽  
ALLISON GOLDMAN ◽  
HARRY SHI ◽  
SUSAN HUYCK ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Efficacy And Safety ◽  
Term Efficacy

Long-term efficacy and safety of vildagliptin add-on therapy in type 2 diabetes mellitus with insulin treatment

2017 ◽  
Vol 123 ◽  
pp. 9-17 ◽  
Author(s):  
Ippei Kanazawa ◽  
Ken-ichiro Tanaka ◽  
Masakazu Notsu ◽  
Sayuri Tanaka ◽  
Nobuaki Kiyohara ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Insulin Treatment ◽  
Efficacy And Safety ◽  
Term Efficacy

Long-term efficacy and safety of biphasic insulin aspart in patients with type 2 diabetes

2004 ◽  
Vol 15 (8) ◽  
pp. 496-502 ◽  
Author(s):  
Bernhard O. Boehm ◽  
Julius A. Vaz ◽  
Lise Brøndsted ◽  
Philip D. Home
Keyword(s):  
Type 2 Diabetes ◽  
Insulin Aspart ◽  
Efficacy And Safety ◽  
Term Efficacy ◽  
Biphasic Insulin Aspart ◽  
Biphasic Insulin

scholarly journals Long-term Efficacy and Safety of Sitagliptin in Elderly Patients with Type 2 Diabetes Mellitus

2016 ◽  
Vol 55 (10) ◽  
pp. 1275-1278 ◽  
Author(s):  
Yuko Tada ◽  
Ippei Kanazawa ◽  
Masakazu Notsu ◽  
Ken-ichiro Tanaka ◽  
Nobuaki Kiyohara ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Elderly Patients ◽  
Efficacy And Safety ◽  
Term Efficacy

Long-Term Efficacy and Safety of Canagliflozin (CANA) in Older Patients with Type 2 Diabetes Mellitus (T2DM) Over 104 Weeks

2014 ◽  
Vol 38 (5) ◽  
pp. S44
Author(s):  
Stewart Harris ◽  
Bruce Bode ◽  
Kaj Stenlöf ◽  
Daniel Sullivan ◽  
Albert Fung ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Older Patients ◽  
Efficacy And Safety ◽  
Term Efficacy
Sign in / Sign up

Export Citation Format

Share Document